Home » 3E Bioventures Capital

Skip to content

FinSMEs

REAL TIME VC & PRIVATE EQUITY DEALS AND NEWS

Search for:

Facebook
Twitter
Linkedin

Navigation

Site navigation

USA
UK
Germany
Canada
China
Russia
India
France
Italy

Home
3E Bioventures Capital

3E Bioventures Capital

healthcare

USA

OncoImmune Raises $56M Series B Financing

Published on September 10, 2020September 10, 2020By FinSMEs

USA

C4 Therapeutics Raises $170M in Funding

Published on June 16, 2020June 16, 2020By FinSMEs

USA

Regenacy Pharmaceuticals Secures $30M in Series A Financing

Published on March 25, 2020March 25, 2020By FinSMEs

profusa

USA

Profusa Closes $45M Series C Financing

Published on August 15, 2018By FinSMEs

cancer

USA

Apexigen Raises $73M in Series B And Series C Financings

Published on August 8, 2018By FinSMEs

healthcare

USA

Ansun BioPharma Secures $85M in Series A Financing

Published on May 14, 2018By FinSMEs

healthcare

China

EpimAb Biotherapeutics Raises $25M in Series A Funding

Published on April 25, 2017By FinSMEs

cancer

USA

OncoImmune Closes $15.0M Series A Funding Round

Published on January 12, 2017By FinSMEs

healthcare

USA

MicuRx Pharmaceuticals Closes $55M Series C Financing

Published on September 26, 2016By FinSMEs

The Daily Deal Newsletter – Sign Up

Email address:

Leave this field empty if you're human:

About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter
FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.

Privacy Policy FinSMEs is owned by FinSMEs Ltd - 86 - 90 Paul Street - London, UK - EC2A 4NE - e-mail: info@finsmes.com

Follow FinSMEs on:

Sign-up now to the Daily Newsletter